文献速递免疫规划

50岁及以上成人接种流感疫苗后静脉血栓栓塞风险:疫苗安全数据链研究

Risk of venous thromboembolism following influenza vaccination in adults aged 50years and older in the Vaccine Safety Datalink.
PubMed 文献 · Vaccine · 2017-09-06

研究采用自身对照病例系列方法,在疫苗安全数据链中评估50岁及以上成人接种流感疫苗后静脉血栓栓塞(VTE)风险。共纳入396例确诊VTE病例,接种后1至10天VTE发生率比为0.89(95%CI 0.69-1.17),与对照期相比无风险升高。事后分析显示当前吸烟者风险升高(IRR=2.57,95%CI 1.06-6.23)。

要点

  • 50岁及以上成人接种流感疫苗后1至10天VTE风险未升高(IRR=0.89,95%CI 0.69-1.17)。
  • 事后分析显示当前吸烟者VTE风险升高(IRR=2.57,95%CI 1.06-6.23)。
  • 接种后1至42天未观察到VTE聚集现象。

核心结论

  • 总体而言,没有证据表明灭活流感疫苗与50岁及以上成人的VTE相关。
  • 事后分析发现当前吸烟者风险升高。
  • 这些发现与既往研究一致,支持该人群每年接种疫苗的安全性。

研究设计与样本

  • 采用自身对照病例系列方法,在疫苗安全数据链(VSD)中纳入2007年至2012年9月至12月期间年龄符合条件、接种流感疫苗(含或不含大流行H1N1)且发生VTE的成人。
  • 通过诊断代码、诊断检测和口服抗凝药处方识别推定VTE病例,并经病历审查验证。
  • 在确诊病例中计算接种后1至10天风险窗相对于9月至12月所有其他观察时间的VTE发生率比。

主要发现

  • 共识别1488例推定病例,审查508例,其中492例(97%)确诊为VTE。
  • 分析纳入396例新发确诊VTE病例。
  • 接种后1至10天VTE风险与对照期相比无升高(IRR=0.89,95%CI 0.69-1.17)。
  • 将接种前所有观察时间删失后结果相似。
  • 事后分析显示当前吸烟者风险升高(IRR=2.57,95%CI 1.06-6.23)。

局限性

  • 事后分析发现当前吸烟者风险升高(IRR=2.57,95%CI 1.06-6.23)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Influenza-like illness and inflammation are known risk factors for venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE). However, few studies have characterized the risk of VTE following influenza vaccination. We examined VTE risk after vaccination in adults 50years old and older within the Vaccine Safety Datalink (VSD). METHODS: We used the self-controlled case series method to determine the risk of VTE among age-eligible adults who received influenza vaccine (with or without pandemic H1N1) and experienced a VTE during the months of September through December in 2007 through 2012. Presumptive VTE cases were identified among VSD participants using diagnostic codes, diagnostic tests, and oral anticoagulant prescription. Potential cases were validated by medical record review. The VTE incidence rate ratio was calculated among confirmed cases for the risk window 1 to 10days after vaccination relative to all other person-time from September through December. RESULTS: Of the 1,488 presumptive cases identified, 508 were reviewed, of which 492 (97%) were confirmed cases of VTE. The analysis included 396 incident, confirmed cases. Overall, there was no increased risk of VTE in the 1 to 10days after influenza vaccination (IRR=0.89, 95% CI 0.69-1.17) compared to the control period. Results were similar when all person-time was censored before vaccination. A post hoc analysis showed an increased risk among current tobacco smokers (IRR=2.57, 95% CI 1.06-6.23). No clustering of VTE was observed in the 1-42days after vaccination. DISCUSSION: Overall, there was no evidence that inactivated influenza vaccine was associated with VTE in adults ≥50years old. An increased risk was found among current smokers in a post hoc analysis. These findings are consistent with previous research and support the safety of annual vaccination in this population.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Vickers ER, McClure DL, Naleway AL, et al. Risk of venous thromboembolism following influenza vaccination in adults aged 50years and older in the Vaccine Safety Datalink. Vaccine. 2017. PMID: 28888342. doi:10.1016/j.vaccine.2017.08.086

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。